软骨
整合素
化学
软骨细胞
骨关节炎
细胞生物学
体内
体外
下调和上调
蛋白多糖
基质金属蛋白酶
细胞外基质
II型胶原
细胞凋亡
癌症研究
信号转导
药理学
表型
RGD基序
生物化学
作者
Yinghuan Jing,Mengzhen Li,Shiyang Li,Zefan Chen,Xinyu Liu,Shan Gao,Yuanhui Zhao,Kangyu Wang
标识
DOI:10.1021/acs.jafc.6c10186
摘要
Abstract Osteoarthritis (OA) features progressive cartilage loss with no effective therapies to slow degeneration. This study investigated sturgeon cartilage peptides (SCPs) for OA repair and identified key bioactive peptides and mechanisms. SCPs, prepared by trypsin hydrolysis, were evaluated in in vitro and in vivo OA models. SCPs markedly improved cartilage damage, reduced matrix degradation, and increased chondrocyte proliferation to 126% (p < 0.05). Multiomics and docking analyses revealed integrin αvβ3-mediated PI3K/Akt pathway activation as the key mechanism, and four bioactive peptides were screened; they promoted S/G2 cell-cycle progression, reducing IL-1β-induced apoptosis from 33% to 19–28% (p < 0.05), and restored COL2A1 and proteoglycan synthesis. Mechanistically, these effects occurred via binding to integrin αvβ3 and upregulation of integrin αV, integrin β3, PI3K, Akt, SOX9, and CCND1, and were attenuated by Cyclo(-RGDfK). Therefore, SCPs improve the OA phenotype by promoting synthesis and repair responses through the αvβ3–PI3K/Akt pathway, and GDR6 (GDFGER) is a lead peptide, providing insights for marine peptide-based OA treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI